BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7206050)

  • 1. Red cell surface antigen and its relationship to survival of patients with transitional cell carcinoma of the bladder.
    Askari A; Colmenares E; Saberi A; Jarman WD
    J Urol; 1981 Feb; 125(2):182-4. PubMed ID: 7206050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens.
    Richie JP; Blute RD; Waisman J
    J Urol; 1980 Jan; 123(1):22-4. PubMed ID: 6985979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
    Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
    Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A, B, O (H) antigenic determinants in superficial transitional cell tumors of bladder.
    Selli C; Cozzolino F; Vercelli D; Mincione GP
    Urology; 1983 Feb; 21(2):132-4. PubMed ID: 6186066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modified immunoperoxidase method for the detection of ABH tissue isoantigens in patients with bladder carcinoma.
    Stul MS; Logghe GN; Bergmans GB; Vanvuchelen JK
    Exp Pathol; 1985; 27(2):119-22. PubMed ID: 3888650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The specific red cell adherence test in transitional cell carcinoma of the bladder before and after radiotherapy in patients with blood group A.
    Wolk FN; Bishop MC
    J Urol; 1983 Jul; 130(1):71-3. PubMed ID: 6345808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
    Gelabert Mas A; Corominas J; Arango O
    Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
    [No Abstract]   [Full Text] [Related]  

  • 9. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
    [No Abstract]   [Full Text] [Related]  

  • 10. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
    Sadoughi N; Rubenstone A; Mlsna J; Davidsohn I
    J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of the detection of ABO surface antigens by indirect immunofluorescence technic in transitional tumors of the bladder].
    Borella T; Loro M; Dato I; Merlo F; Giudici M
    Minerva Med; 1986 Sep; 77(34-35):1527-32. PubMed ID: 3531921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. II. Results of a long-term follow-up and technical problems].
    Kumon H; Nasu Y; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):731-8. PubMed ID: 6492527
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of urine cytology with ABO(H) antigenicity in transitional cell carcinoma of the bladder.
    Das G; Glashan RW
    J Clin Pathol; 1988 May; 41(5):538-9. PubMed ID: 3384984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on blood group isoantigens in uroepithelium. I. Determination of isoantigens in non-malignant epithelium of tumor-bearing bladder].
    Abe R
    Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):1049-58. PubMed ID: 4079195
    [No Abstract]   [Full Text] [Related]  

  • 15. [A B H isoantigens in bladder cancer. Preliminary study].
    Hernáez Manrique I; Rodríguez Trinidad A; Gastaminza A; Recarte Mendiluce JM
    Actas Urol Esp; 1983; 7(2):113-6. PubMed ID: 6880907
    [No Abstract]   [Full Text] [Related]  

  • 16. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. III. Detection by PAP method and a classification of staining pattern].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):739-43. PubMed ID: 6208400
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of specific red-cell adherence and immunoperoxidase staining techniques for ABO(H) blood-group cell-surface antigens on superficial transitional cell carcinoma of the bladder.
    Boileau MA; Cowles RS; Schmidt KL; Schmidt WA
    J Surg Oncol; 1985 Oct; 30(2):72-9. PubMed ID: 3908825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of the cell surface antigens with stage and grade in cancer of the bladder.
    Emmott RC; Javadpour N; Bergman SM; Soares T
    J Urol; 1979 Jan; 121(1):37-9. PubMed ID: 759641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinoma.
    Decenzo JM; Howard P; Irish CE
    J Urol; 1975 Dec; 114(6):874-8. PubMed ID: 1195466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunofluorescence study of the distribution of ABH cell surface antigens in bladder tumours (author's transl)].
    Vallancien G; Rouger P; Leclerc JP; Kuss R
    Sem Hop; 1982 May; 58(19):1161-4. PubMed ID: 6285497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.